Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
DuPont and the biotech firm Caribou Biosciences have agreed to cross-license their intellectual property related to the new gene-editing tool called CRISPR/Cas. Caribou was founded in 2011 by CRISPR research pioneer Jennifer Doudna of the University of California, Berkeley, and colleagues. DuPont obtained its technology in June through a license from Vilnius University. DuPont made an equity investment in Caribou as part of the biotech firm’s recent Series A funding round. The two firms also will collaborate on research.
This article has been sent to the following recipient: